Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Preliminary results from IMpact-RSV trial

July 17, 1997

Sequus and Sam Yang sign marketing agreement for Amphocil

July 16, 1997

Katayama's new cephems

July 16, 1997

Toyama claims antibacterial agents

July 16, 1997

New carbapenem ester prodrug claimed by Nippon Lederle

July 16, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

UCLA isolates new antimicrobial agents

July 14, 1997

In vitro activity of novel pneumocandin antifungal agent

July 11, 1997

Lupulon for the treatment of MRSA

July 10, 1997

Transcell and Merck & Co. collaborate on antibacterial research

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...